A Study on Regulation of HDAC1 2 Activity by Ube3a Implication in Angelman Syndrome

Main Article Content

Pavan Kumar Ediga
Chinmay Vilas Phadtare


The purpose of this research is to learn how Ube3a affects HDAC activity in individuals with Angelman syndrome. Heterozygous Ube3a-deficient mice were bought from the lab and kept in the usual conditions with pelleted food and water. Sigma Stat was used for the statistical analysis. Our results show that Ube3a controls HDAC1 and HDAC2 transcription.

Article Details

How to Cite
Ediga, P. K. ., & Phadtare, C. V. . (2023). A Study on Regulation of HDAC1 2 Activity by Ube3a Implication in Angelman Syndrome. Journal of Coastal Life Medicine, 11(1), 2897–2903. Retrieved from https://www.jclmm.com/index.php/journal/article/view/773


Kuhnle, S., Mothes, B., Matentzoglu, K., Scheffner, M., & Whitby, F. G. (2011). The N‐terminal domain of UBE3A ubiquitin ligase activates proteasomal degradation of HDAC2. Journal of Biological Chemistry, 286(32), 28579-28587.

Higashimori, H., Schin, C. S., Chiang, M. S. R., Morel, L., Shoneye, T. A., Nelson, D. L., ... & Monteggia, L. M. (2019). Selective deletion of astroglial FMRP dysregulates glutamate transporter GLT1 and contributes to fragile X syndrome phenotypes in vivo. Journal of Neuroscience, 39(35), 7079-7095.

Sun, J., Zhu, G., Liu, Y., Standley, S., Ji, A., Tunuguntla, R., ... & Chen, J. K. (2015). UBE3A regulates synaptic plasticity and learning and memory by controlling SK2 channel endocytosis. Cell Reports, 12(3), 449-461.

Hsiao, J. S., & Williams, C. A. (2019). Angelman syndrome: from discovery to intervention. Journal of Neurodevelopmental Disorders, 11(1), 1-12.

Tan, W. H., Bird, L. M., & Thibert, R. L. (2016). Williams syndrome: a review of recent research. Current Psychiatry Reports, 18(12), 1-7.

Heck, D. H., & Philpot, B. D. (2019). The molecular logic of activity-dependent synaptic pruning underlying visual map formation. The Journal of Neuroscience, 39(36), 7078-7089.

Hu, J. H., Zhang, H., Wagey, R., Krieger, C., Pelech, S. L., & Roder, J. C. (2017). Ubiquitin ligase TRIM3 controls hippocampal plasticity and learning by regulating synaptic γ-actin levels. Journal of Cell Science, 130(4), 716-731.

Albrecht, U., Sutcliffe, J. S., Cattanach, B. M., Beechey, C. V., Armstrong, D., Eichele, G., & Lalande, M. (1997). Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons. Nature Genetics, 17(1), 75-78.

Mulherkar, S. A., Sharma, J., Jana, N. R., & Narayanan, V. (2017). UBE3A-mediated regulation of brain and synaptic plasticity. Journal of Neurochemistry, 143(5), 464-477.

Kuhnle, S., Haverkamp, S., Hoppe, T., & Matentzoglu, K. (2019). The E3 ubiquitin ligase CHIP/MARCH-V promotes degradation of HMGB1 and limits neuroinflammation. EMBO Reports, 20(12), e48662.

Judson, M. C., Wallace, M. L., Sidorov, M. S., Burette, A. C., Gu, B., van Woerden, G. M., ... & Philpot, B. D. (2016). GABAergic neuron-specific loss of Ube3a causes Angelman syndrome-like EEG abnormalities and enhances seizure susceptibility. Neuron, 90(1), 56-69.

Rougeulle, C., Cardoso, C., & Fontes, M. (2020). Ubiquitin ligase-dependent regulation of the Angelman syndrome protein UBE3A during neuronal development and in neurodevelopmental disorders. Molecular Autism, 11(1), 1-11.